Andrzej Benkowski
Technical Manager, Probiotics & Dietary Supplements
As the Technical Manager at Eurofins Center of Excellence for Probiotics, Andrzej Benkowski brings over 18 years of expertise in biotics quality management, testing, and technology. With a strong technical background in food microbiology, Andrzej specializes in contract R&D, method development, and pioneering technologies for probiotic evaluation.
Since 2019, Andrzej has chaired the International Probiotic Association (IPA) Technical Committee and has been a member of the IPA Board of Directors since early 2024. He also contributes to the IPA Postbiotics Committee and has served as the IPA expert liaison with the International Organization for Standardization (ISO) TC34/SC9 Working Group 11 since 2022, co-convening their Enumeration Subgroup.
Andrzej is dedicated to advancing the biotics industry by setting rigorous standards and driving innovation with a focus on quality.
Outside of his professional and scientific achievements, Andrzej is a member of the Eurofins Madison Site Employee Engagement Team and manages the Community Supported Agriculture (CSA) Program for the site. A founding member of the funk band Steez, he also plays saxophone, synthesizers, and vocals. Andrzej enjoys the outdoors, spending time with his family, and pretending to be a coffee aficionado. Additionally, he has a passion for collecting sneakers and fitted hats.
Below are resources from Andrzej:
Infrared spectroscopy is a powerful analytical tool for rapid, nondestructive measurement. But despite its advantages, IR often develops a reputation for being unreliable or not accurate as primary methods. Keep reading to learn more about how to build and validate a reliable model.
Explore why “food safety culture” is often overcomplicated and how CEO leadership, clear expectations, and accountability truly drive food safety success.
As we look back on 2025, one thing is clear: innovation didn’t slow down, it got sharper. Across major food, beverage, supplement, and ingredient tradeshows this year, the conversation shifted away from flashy novelty and toward proof, performance, and practicality. Here is our perspective on what to expect in 2026.
How do you know when it makes sense to bring in product development support and when it doesn’t? Based on what we see across brands, ingredient companies, and startups, here’s a practical way to think about it.
The rapid rise of mocktails and alcohol alternatives signals a deeper shift in consumer behavior. As the category matures, brands are discovering that removing alcohol is only the beginning.
Ethylene glycol (EG) and diethylene glycol (DEG) are toxic industrial chemicals that have no place in consumer health products. Unfortunately, products ranging from cough syrups to dietary supplements have been found to contain these contaminants, often with tragic consequences.
As the category of sports nutrition matures, so does the science behind it, and few ingredients illustrate that shift better than creatine. Once viewed as a niche performance supplement, creatine has entered the mainstream, driven by a growing body of research, broader consumer education, and innovation in product formats.
For food manufacturers, product labeling represents both a regulatory responsibility and a powerful tool for brand differentiation. Label claims help consumers make informed purchasing decisions while allowing brands to highlight the unique nutritional or functional benefits of their products. These claims are tightly regulated by the U.S. Food and Drug Administration (FDA), requiring strict adherence to defined standards, substantiation protocols, and disclosure rules.
Botanical Reference Materials (BRMs) are the foundation of reliable High Performance Thin- Layer Chromatography (HPTLC) identity testing. They provide the verified chromatographic fingerprint against which botanical samples are compared. Learn how to safeguarding both industry integrity and consumer confidence.
Supplement and OTC products often require non-traditional testing approaches such as radiolabel studies or DEA Schedule I compound analysis. Knowing when and how to apply these specialized methods is key to regulatory success.
